236 related articles for article (PubMed ID: 19443539)
1. Genome-wide scan identifies novel modifier loci of acromegalic phenotypes for isolated familial somatotropinoma.
Khoo SK; Pendek R; Nickolov R; Luccio-Camelo DC; Newton TL; Massie A; Petillo D; Menon J; Cameron D; Teh BT; Chan SP
Endocr Relat Cancer; 2009 Sep; 16(3):1057-63. PubMed ID: 19443539
[TBL] [Abstract][Full Text] [Related]
2. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
[TBL] [Abstract][Full Text] [Related]
3. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
[TBL] [Abstract][Full Text] [Related]
4. Pituitary adenoma predisposition caused by germline mutations in the AIP gene.
Vierimaa O; Georgitsi M; Lehtonen R; Vahteristo P; Kokko A; Raitila A; Tuppurainen K; Ebeling TM; Salmela PI; Paschke R; Gündogdu S; De Menis E; Mäkinen MJ; Launonen V; Karhu A; Aaltonen LA
Science; 2006 May; 312(5777):1228-30. PubMed ID: 16728643
[TBL] [Abstract][Full Text] [Related]
5. [AIP mutations in familial and sporadic pituitary adenomas: local experience and review of the literature].
Fajardo-Montañana C; Daly AF; Riesgo-Suárez P; Gómez-Vela J; Tichomirowa MA; Camara-Gómez R; Beckers A
Endocrinol Nutr; 2009; 56(7):369-77. PubMed ID: 19883897
[TBL] [Abstract][Full Text] [Related]
6. A novel truncating AIP mutation, p.W279*, in a familial isolated pituitary adenoma (FIPA) kindred.
Cansu GB; Taşkıran B; Trivellin G; Faucz FR; Stratakis CA
Hormones (Athens); 2016 Jul; 15(3):441-444. PubMed ID: 27838609
[TBL] [Abstract][Full Text] [Related]
7. Aryl hydrocarbon receptor interacting protein (AIP) gene mutation analysis in children and adolescents with sporadic pituitary adenomas.
Georgitsi M; De Menis E; Cannavò S; Mäkinen MJ; Tuppurainen K; Pauletto P; Curtò L; Weil RJ; Paschke R; Zielinski G; Wasik A; Lubinski J; Vahteristo P; Karhu A; Aaltonen LA
Clin Endocrinol (Oxf); 2008 Oct; 69(4):621-7. PubMed ID: 18410548
[TBL] [Abstract][Full Text] [Related]
8. Mutations of the gene for the aryl hydrocarbon receptor-interacting protein in pituitary adenomas.
Cazabat L; Guillaud-Bataille M; Bertherat J; Raffin-Sanson ML
Horm Res; 2009; 71(3):132-41. PubMed ID: 19188737
[TBL] [Abstract][Full Text] [Related]
9. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
10. Hyperplasia-adenoma sequence in pituitary tumorigenesis related to aryl hydrocarbon receptor interacting protein gene mutation.
Villa C; Lagonigro MS; Magri F; Koziak M; Jaffrain-Rea ML; Brauner R; Bouligand J; Junier MP; Di Rocco F; Sainte-Rose C; Beckers A; Roux FX; Daly AF; Chiovato L
Endocr Relat Cancer; 2011 Jun; 18(3):347-56. PubMed ID: 21450940
[TBL] [Abstract][Full Text] [Related]
11. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
Beckers A; Daly AF
Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
[TBL] [Abstract][Full Text] [Related]
12. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
[TBL] [Abstract][Full Text] [Related]
14. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein gene mutations.
Georgitsi M; Raitila A; Karhu A; Tuppurainen K; Mäkinen MJ; Vierimaa O; Paschke R; Saeger W; van der Luijt RB; Sane T; Robledo M; De Menis E; Weil RJ; Wasik A; Zielinski G; Lucewicz O; Lubinski J; Launonen V; Vahteristo P; Aaltonen LA
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4101-5. PubMed ID: 17360484
[TBL] [Abstract][Full Text] [Related]
15. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
[TBL] [Abstract][Full Text] [Related]
16. Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications.
Jaffrain-Rea ML; Angelini M; Gargano D; Tichomirowa MA; Daly AF; Vanbellinghen JF; D'Innocenzo E; Barlier A; Giangaspero F; Esposito V; Ventura L; Arcella A; Theodoropoulou M; Naves LA; Fajardo C; Zacharieva S; Rohmer V; Brue T; Gulino A; Cantore G; Alesse E; Beckers A
Endocr Relat Cancer; 2009 Sep; 16(3):1029-43. PubMed ID: 19556287
[TBL] [Abstract][Full Text] [Related]
17. Germline inactivating mutations of the aryl hydrocarbon receptor-interacting protein gene in a large cohort of sporadic acromegaly: mutations are found in a subset of young patients with macroadenomas.
Cazabat L; Libè R; Perlemoine K; René-Corail F; Burnichon N; Gimenez-Roqueplo AP; Dupasquier-Fediaevsky L; Bertagna X; Clauser E; Chanson P; Bertherat J; Raffin-Sanson ML
Eur J Endocrinol; 2007 Jul; 157(1):1-8. PubMed ID: 17609395
[TBL] [Abstract][Full Text] [Related]
18. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
19. Familial isolated pituitary adenoma: evidence for genetic heterogeneity.
Toledo RA; Lourenço DM; Toledo SPA
Front Horm Res; 2010; 38():77-86. PubMed ID: 20616498
[TBL] [Abstract][Full Text] [Related]
20. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Daly AF; Beckers A
Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
